VKTX Snapshot
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.
Market Capitalization$171,770,000
Price to Sales0.00
Earnings per Share$-0.7330
PE RatioNone
Most Recent Close$2.2500
52 Week High$7.2
52 Week Low$2.15
50-Day Moving Average$2.729
200-Day Moving Average$4.58
All data are from Alpha Vantage as of today. For more infomation on VKTX see Stock Dividend, Valuation, Price and Financial Data for Investors